Choreo LLC’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $503K | Buy |
4,002
+1,298
| +48% | +$163K | 0.01% | 890 |
|
2025
Q1 | $299K | Sell |
2,704
-1,061
| -28% | -$117K | ﹤0.01% | 1089 |
|
2024
Q4 | $516K | Buy |
3,765
+1,156
| +44% | +$158K | 0.01% | 890 |
|
2024
Q3 | $298K | Buy |
2,609
+868
| +50% | +$99.1K | ﹤0.01% | 1207 |
|
2024
Q2 | $244K | Buy |
+1,741
| New | +$244K | ﹤0.01% | 1216 |
|